IL6 and cancer: Increased levels in serum and cancer tissue of IL-6 have been related to poor prognosis and lower survival rates in several human cancers (such as breast, renal, gastric, prostate, leukemia) [21–23], while down-regulation of IL-6 might be related to a better response to treatment representing a potential target for anticancer therapy [22].